Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. - Wikidata - wikimedia - TriplyDB

Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.

Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.

http://www.wikidata.org/entity/Q34721065

about

Opioids in pregnancy and neonatal abstinence syndrome Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome Review of the assessment and management of neonatal abstinence syndrome Incidence of narcotic abuse during pregnancy in northwestern Ontario: three-year prospective cohort study Prescription opioid epidemic and infant outcomes.Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations How long should infants at risk of drug withdrawal be monitored after birth?Epidemiological Evidence for a Decreasing Incidence of Neonatal Abstinence Syndrome, 2000-11.Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.The relationship between gestational age and the severity of neonatal abstinence syndrome.Maternal buprenorphine treatment and infant outcome.Monitoring neonatal abstinence syndrome in buprenorphine-exposed in vitro fertilization twins: A case study.A Quality Improvement Initiative to Increase Scoring Consistency and Accuracy of the Finnegan Tool: Challenges in Obtaining Reliable Assessments of Drug Withdrawal in Neonatal Abstinence Syndrome.Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.Does concurrent in utero exposure to buprenorphine and antidepressant medications influence the course of neonatal abstinence syndrome?Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial

P2860

Q28082706-17F7C3DB-D5D7-4396-99FD-0CC98C80A7F1 Q33760424-A0208017-C08B-4D99-BBCF-E2ABCE786D4B Q34090556-E24CD8CF-DB6E-4BDF-B477-DE8C8675E962 Q34199044-6A1259EB-F077-428F-A498-CF8340E37E30 Q34337831-DB675052-E575-4738-9D54-7AA169A5BDBF Q35544765-5BA6A5F6-244C-4E36-ABDD-EAE8980A761D Q35605499-69D73428-533E-4852-95CC-5BE4DB6A0B94 Q36730570-5E28E389-84D6-42F1-A832-F634B6026A02 Q37221649-8B9D3E1A-D4DF-4440-A0E6-D6FA12D561ED Q38195934-54D847AE-4C33-4A63-AC28-1884F9D72794 Q40020329-31D72217-3E1B-4EDF-AB7F-33E5C18CC8BE Q40202958-13082993-F1F9-4700-954E-CEE2BAD5B0F8 Q40423803-FCB6F983-DE7A-4C4D-9AEF-BE1BFAB70343 Q47712360-B3874583-8987-463B-BF5F-D341CAD4D005 Q48027117-9BB635F2-AC47-4ACA-9B92-39D28F08F898 Q50088929-CD767F1D-859B-455B-BBDE-139E3FB482EA Q50650996-8A23198C-D077-4776-A951-A3388DCFC24A Q51012798-D20C3F77-39CD-46C1-BA9C-4623840A2F0C Q57270649-B4528B7C-036C-4199-B066-3B8DC11884F6

P2860

Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.

http://www.wikidata.org/entity/Q34721065

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Predicting treatment for neona ...... on opioid agonist medication.

@ast

Predicting treatment for neona ...... on opioid agonist medication.

@en

Predicting treatment for neona ...... on opioid agonist medication.

@nl

type

label

Predicting treatment for neona ...... on opioid agonist medication.

@ast

Predicting treatment for neona ...... on opioid agonist medication.

@en

Predicting treatment for neona ...... on opioid agonist medication.

@nl

prefLabel

Predicting treatment for neona ...... on opioid agonist medication.

@ast

Predicting treatment for neona ...... on opioid agonist medication.

@en

Predicting treatment for neona ...... on opioid agonist medication.

@nl

P1433

Q34721065-0E2E527D-344A-4548-BCA7-B4EC2612A38D

P1476

Q34721065-5B911542-478D-4B54-ABD4-043FA64DF997

P2093

Q34721065-2B0E801C-7555-4244-A6FB-4266DCBC5F7D

Q34721065-3F896023-85BD-4855-9F28-D247FA0A4125

Q34721065-6516556D-1D47-4779-B36A-3AAB7DD6D28F

Q34721065-D3AC0A3E-6756-4FC0-88BA-FF822B3F8665

Q34721065-D9391D73-9459-4538-B34B-7946A5602DEE

Q34721065-E083011D-7FBD-4B83-805C-4B1B5DB88000

P2860

Q34721065-0D24AEDA-667C-45E5-9CEC-181C67E5D674

Q34721065-185BA251-422D-414B-B62F-7BBFF7992E05

Q34721065-187E842D-8B2D-48CB-B4BF-C45BCC87E35D

Q34721065-1ADFEF21-6DD5-4A15-B092-562125331E00

Q34721065-388F1C1F-389B-44CD-8D36-7A026C78FFBB

Q34721065-468FDC86-4E85-4B1B-BF80-DAC1A6B8C7CE

Q34721065-4EFDEC32-F47E-4E2F-9FCF-22D15987A1E3

Q34721065-548E15D3-58C7-46AA-8B96-D3899EDCEA85

Q34721065-563F1DEE-2AA2-4F72-BF39-2DAAA32496AF

Q34721065-578587B1-F0CD-4473-ABEC-011B5D0F6DC2

P304

Q34721065-4395DD12-7030-4D1C-BEC5-F225EE132019

P31

Q34721065-9B6764D3-A154-4AF1-A662-7D047E63F9E5

P356

Q34721065-D516694C-6884-4CE4-8706-0D80B4F380CA

P407

Q34721065-A77DBF1C-9FF5-4D3C-B6CD-3287CF23A885

P478

Q34721065-EE24218B-4DA2-4C6A-982F-1DD832EEF28B

P50

Q34721065-46E29469-6461-4573-BF04-BD7D7B627178

Q34721065-9AB70D1A-EB9D-4710-B44F-135B4D4CC922

P577

Q34721065-D12887BF-E3B6-4839-B5D9-0C34C3B5ECD2

P5875

Q34721065-B1D1A992-FF11-4E7D-A3BE-12AC7F1C11C5

P698

Q34721065-983D530C-A97B-47FB-8CE6-8F862C9265E9

P921

Q34721065-244449dc-73c1-49ac-aec4-aa42cede50db

P932

Q34721065-7FE110E3-B219-4973-88E6-106A05EE4E82

P356

J.1360-0443.2012.04038.X

P1433

P1476

Predicting treatment for neona ...... on opioid agonist medication.

@en

P2093

Amber M Holbrook

http://www.w3.org/2001/XMLSchema#string

Amy L Salisbury

http://www.w3.org/2001/XMLSchema#string

Karol Kaltenbach

http://www.w3.org/2001/XMLSchema#string

Mara G Coyle

http://www.w3.org/2001/XMLSchema#string

Peter R Martin

http://www.w3.org/2001/XMLSchema#string

Sarah H Heil

http://www.w3.org/2001/XMLSchema#string

P2860

Neonatal abstinence syndrome after methadone or buprenorphine exposure

Neonatal abstinence syndrome.

Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis.

Infant autonomic functioning and neonatal abstinence syndrome

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Drug addiction during pregnancy: correlations between the placental health and the newborn's outcome - elaboration of a predictive score.

Use of buprenorphine in pregnancy: patient management and effects on the neonate.

Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?

Maternal methadone dose and neonatal withdrawal.

Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned

P304

45-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1360-0443.2012.04038.X

http://www.w3.org/2001/XMLSchema#string

P407

P478

107 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Hendrée E Jones

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232740094

http://www.w3.org/2001/XMLSchema#string

P698

23106926

http://www.w3.org/2001/XMLSchema#string

P921

P932

4268864

http://www.w3.org/2001/XMLSchema#string